Scarica l'app Stockscreener
2.86
1.06%
0.03
Dopo l'orario di chiusura:
2.86
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVRX Giù?
Forum
Previsione
Precedente Chiudi:
$2.83
Aprire:
$2.83
Volume 24 ore:
372.76K
Relative Volume:
0.50
Capitalizzazione di mercato:
$76.19M
Reddito:
$59.07M
Utile/perdita netta:
$-52.66M
Rapporto P/E:
-1.4229
EPS:
-2.01
Flusso di cassa netto:
$-40.16M
1 W Prestazione:
-4.98%
1M Prestazione:
+20.68%
6M Prestazione:
-61.71%
1 anno Prestazione:
-63.71%
Intervallo 1D:
$2.70
$2.86
Intervallo di 1 settimana:
$2.70
$3.11
Portata 52W:
$2.20
$11.30
Cvrx Inc Stock (CVRX) Company Profile
Nome
Cvrx Inc
Settore
Industria
Telefono
(763) 416-2850
Indirizzo
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
2.86 | 75.40M | 59.07M | -52.66M | -40.16M | -2.01 |
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Reiterato | Lake Street | Buy |
| 2024-05-01 | Ripresa | Craig Hallum | Buy |
| 2024-05-01 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Iniziato | Lake Street | Buy |
| 2022-07-18 | Iniziato | Craig Hallum | Buy |
| 2021-07-26 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-26 | Iniziato | Piper Sandler | Overweight |
| 2021-07-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Cvrx Inc Borsa (CVRX) Ultime notizie
Investigation launched into CVRx over DOJ probe, sales issues, and sudden CRO firing. - Pluang
HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop - PR Newswire
CVRX stock edges higher as investors watch neuromodulation growth - ad-hoc-news.de
CVRX stock benefits as Barostim heart failure therapy gains new Medicare Advantage coverage - ad-hoc-news.de
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc.CVRX - PR Newswire
CVRx Secures Devoted Health Coverage for Barostim Therapy - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating CVRx, Inc. (CVRX) And Encourages Shareholders to Connect - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CVRx, Inc. (CVRX) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX) - qz.com
CVRx has an activist investor urging it to get acquired - MassDevice
CVRx Responds to Letter from Pointillist Family Office - marketscreener.com
3 Penny Stocks With At Least $70M Market Cap - Sahm
CVRx earns new Medicare Advantage coverage policy for Barostim - MassDevice
CVRx Inc. Faces Securities Law Investigation Over Revenue Guidance Cut and DOJ Demand - kalkine.ca
Investor holding 5.5% of CVRx urges board to pursue sale By Investing.com - Investing.com Nigeria
Jorey Chernett, Owner of More Than 5.5% of Ou - Moomoo
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy - GlobeNewswire
Jorey Chernett Urges Board to Launch Sale Process - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating CVRx, Inc. (CVRX) And Encourages Investors to Connect - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Encourages CVRx, Inc. (CVRX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CVRx, Inc. (CVRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
CVRx (CVRX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Eastern Progress
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CVRx, Inc. (CVRX) And Encourages Investors to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Law firm investigates CVRx for possible securit... - Pluang
Cantor Fitzgerald Maintains CVRx Inc(CVRX.US) With Buy Rating, Cuts Target Price to $5 - Moomoo
Cantor cuts CVRx stock price target on sales execution challenges By Investing.com - Investing.com South Africa
CVRX Q2 2026 Earnings: Modest EPS Beat Offset by 10.71% Share SlidePositive Surprise Momentum - vinanet.vn
Cantor cuts CVRx stock price target on sales execution challenges - Investing.com
Cantor Fitzgerald Issues Pessimistic Forecast for CVRx (NASDAQ:CVRX) Stock Price - MarketBeat
Johnson & Johnson Invests $20.69 Billion in CVRx, Inc. $CVRX - MarketBeat
CVRX Q2 2026 Earnings: Narrower-Than-Expected Loss Fuels 4.76% Stock GainDividend Increase Stocks - Vinanet
CVRx, Inc. (CVRX) investor Jorey Chernett discloses 5.5% beneficial stake - Stock Titan
Cvrx COO Brent Binkowski sells $3,338 in company stock By Investing.com - Investing.com South Africa
CVRX Q2 2026 Earnings: Narrower-than-Expected Loss Lifts Shares 7.7%Guidance vs Actual - vinanet.vn
Cvrx COO Brent Binkowski sells $3,338 in company stock - Investing.com
Cvrx COO Brent Binkowski buys $76,432 in company stock By Investing.com - Investing.com Australia
CVRx (NASDAQ:CVRX) COO Brent Binkowski Buys 26,223 Shares of Stock - MarketBeat
Cvrx COO Brent Binkowski buys $76,432 in company stock - Investing.com
CVRx (CVRX) COO Brent Binkowski purchases 26,223 shares in open-market buy - Stock Titan
Insider Purchase: CHIEF OPERATING OFFICER of $CVRX Buys 26,223 Shares - Moomoo
CVRx (CVRX) Q2 2026 Earnings Call Transcript - AOL.com
HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages - GlobeNewswire
CVRx (CVRX) COO executes 1,309-share sell-to-cover under Rule 10b5-1 plan - Stock Titan
Block & Leviton investigates CVRx for possible securities law violations after revenue guidance cut. - Pluang
CVRx Eyes Barostim Growth as Coverage Gains and BENEFIT-HF Trial Launches - MarketBeat
CCORF Maintains CVRx Inc(CVRX.US) With Buy Rating, Cuts Target Price to $5 - Moomoo
CVRx chief revenue officer exits amid slowing sales and execution concerns - The Business Journals
CVRx replaces chief revenue officer amid sales transition - The Globe and Mail
Cvrx Inc Azioni (CVRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.29%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):